Oramed Pharmaceuticals
ORMP
#8966
Rank
โ‚น15.43 B
Marketcap
โ‚น377.11
Share price
0.25%
Change (1 day)
97.73%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น76.94. In 2024 the company made an earnings per share (EPS) of -โ‚น45.60 a decrease over its 2023 EPS that were of โ‚น13.30.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-262.31%
2024-โ‚น45.60-442.86%
2023โ‚น13.30-114.89%
2022-โ‚น89.2920.51%
2021-โ‚น74.0939.29%
2020-โ‚น53.19-31.71%
2019-โ‚น77.89-4.65%
2018-โ‚น81.698.86%
2017-โ‚น75.04-9.2%
2016-โ‚น82.6429.85%
2015-โ‚น63.648.06%
2014-โ‚น58.895.08%
2013-โ‚น56.043.51%
2012-โ‚น54.14137.5%
2011-โ‚น22.80-60%
2010-โ‚น56.99-0%
2009-โ‚น56.99-16.67%
2008-โ‚น68.39-25%
2007-โ‚น91.19700%
2006-โ‚น11.40303.56%
2005-โ‚น2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น408.02 430.30%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น243.14 216.01%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น580.39-854.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น18.05-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.50-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel